IKTInhibikase Therapeutics, Inc.Aug 15, 2024Q2 2024
Read transcript →Inhibikase Therapeutics, Inc. (IKT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.30
+3.85%
Mkt Cap $287.83M
IKTInhibikase Therapeutics, Inc.Aug 15, 2024IKTInhibikase Therapeutics, Inc.May 17, 2024Q1 2024
Read transcript →IKTInhibikase Therapeutics, Inc.Mar 28, 2024Q4 2023
Read transcript →IKTInhibikase Therapeutics, Inc.Nov 15, 2023Q3 2023
Read transcript →IKTInhibikase Therapeutics, Inc.Aug 15, 2023Q2 2023
Read transcript →IKTInhibikase Therapeutics, Inc.May 16, 2023Q1 2023
Read transcript →IKTInhibikase Therapeutics, Inc.Apr 3, 2023Q4 2022
Read transcript →IKTInhibikase Therapeutics, Inc.Nov 15, 2022Q3 2022
Read transcript →IKTInhibikase Therapeutics, Inc.Aug 15, 2022Q2 2022
Read transcript →IKTInhibikase Therapeutics, Inc.May 17, 2022Q1 2022
Read transcript →IKTInhibikase Therapeutics, Inc.Apr 1, 2022Q4 2021
Read transcript →